2026 NPPES data Otology & Neurotology Physician NPI 1972846491 MD
Verify on CMS →

THOMAS MUELLEMAN, MD

Otology & Neurotology Physician in OVERLAND PARK, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
588
Medicare Part D claims · 221 beneficiaries · Otology & Neurotology Physician avg: 401
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
68.3495/100
▼ 15 pts below national avg 83.1 · [object Object]
Industry payments
$410.5
11 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

THOMAS MUELLEMAN, MD reported a CMS MIPS final score of 68.3495/100 — below the 83.1 national average — and filed 588 Medicare Part D claims in 2023.

68.3495/100
MIPS score · -15 vs avg
588
Part D claims, 2023
96%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

THOMAS MUELLEMAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

68 7th percentile higher than 7% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). This entry sits in this band. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

THOMAS MUELLEMAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about THOMAS MUELLEMAN, MD?

Below national average

NPI registry status

Active

Issued 04/03/2013

NPI 1972846491

Primary specialty

Otology & Neurotology Physician

Rare

333 US NPIs in this specialty

Medicare Part D claims

588 47% vs specialty avg

2023 prescription claims

Specialty avg: 401

MIPS final score

68.3495/100 14.750499999999988% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Kansas

How Otology & Neurotology Physician compares to other specialties among Kansas providers

Kansas providers

Otology & Neurotology Physician share within Kansas

1. Otology & Neurotology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otology & Neurotology Physician share within Kansas

Medicare quality performance — MIPS

THOMAS MUELLEMAN, MD's 2023 MIPS final score plotted against the Otology & Neurotology Physician national average

Below national average
MIPS Final Score
68.3495/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otology & Neurotology Physician) — 68.3495/100 vs national avg 83.1

0%100%National avg83%68.3%
MIPS final score (Otology & Neurotology Physician) — 68.3495/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

THOMAS MUELLEMAN, MD appears in the CMS NPPES registry as a Otology & Neurotology Physician provider holding MD credentials at 4550 W 109TH ST STE 310, OVERLAND PARK, KS, 66211, with a listed phone of (816) 531-7373. NPI 1972846491 was issued on 04/03/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MUELLEMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 588 prescription claims written by this provider, covering 221 Medicare beneficiaries and totaling roughly $12K in drug spend, split 4% brand-name and 96% generic by claim count, with an opioid prescribing rate of 10.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 68.3495/100 for the 2023 performance year (Quality 76.5769, Cost 30.4215), compared with the national average of 83.1.

Otology & Neurotology Physician is a narrow specialty nationwide, with 333 enrolled providers across 46 states and an average of 401 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4550 W 109TH ST STE 310
OVERLAND PARK, KS 66211

Provider Details

NPI 1972846491
Specialty Otology & Neurotology Physician
Credentials MD
Gender Male
NPI Issued 04/03/2013

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

68.3495
Final Score
Avg: 83.1
76.5769
Quality
30.4215
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where THOMAS MUELLEMAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ASCENTIST PHYSICIANS GROUP LLC
LEES SUMMIT, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for THOMAS MUELLEMAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$411

Largest payer

Advanced Bionics, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

THOMAS MUELLEMAN, MD — brand share 4.0%
Specialty average (est.)

4% brand-name claims vs 96% generic, on 588 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

588
Total Claims
$12K
Total Drug Cost
221
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
690
Total Day Supply
11,910
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$2K
Generic Drug Cost
$10K
Opioid Claims
60 (10.2% rate)
Antibiotic Claims
102

Patient Demographics

Average Patient Age
72.9 years
Avg HCC Risk Score
1.14
Gender Split
60% female / 40% male
Age Distribution
<65: 27, 65-74: 98, 75-84: 67, 85+: 29

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What THOMAS MUELLEMAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ofloxacin
71
Cephalexin
59
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
53
Triamterene-Hydrochlorothiazid
Triamterene/Hydrochlorothiazid
43
Prednisone
38
Meclizine Hcl
27
Ciprofloxacin-Dexamethasone
Ciprofloxacin Hcl/Dexameth
26
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
24
Venlafaxine Hcl Er
Venlafaxine Hcl
24
Dexamethasone Sodium Phosphate
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otology & Neurotology Physician Overview

How THOMAS MUELLEMAN, MD fits within the Otology & Neurotology Physician landscape nationally.

333
Otology & Neurotology Physician Providers in US
46
States with Otology & Neurotology Physician
401
Avg Claims per Provider

THOMAS MUELLEMAN, MD's 588 claims are above the specialty average of 401.

Nearby Otology & Neurotology Physician Providers in Kansas

Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as MUELLEMAN.

Compare Otology & Neurotology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is THOMAS MUELLEMAN, MD's specialty?
THOMAS MUELLEMAN, MD specializes in Otology & Neurotology Physician and practices in OVERLAND PARK, Kansas. Credentials: MD.
How much does THOMAS MUELLEMAN, MD prescribe under Medicare Part D?
In 2023, THOMAS MUELLEMAN, MD wrote 588 Medicare Part D claims totaling $12K in drug costs for 221 beneficiaries.
What is THOMAS MUELLEMAN, MD's Medicare quality score?
THOMAS MUELLEMAN, MD has a CMS MIPS Final Score of 68.3495/100 (Quality: 76.5769, Cost: 30.4215). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is THOMAS MUELLEMAN, MD located?
THOMAS MUELLEMAN, MD is located at 4550 W 109TH ST STE 310, OVERLAND PARK, KS, 66211. Phone: (816) 531-7373.
What is THOMAS MUELLEMAN, MD's NPI number?
THOMAS MUELLEMAN, MD's National Provider Identifier (NPI) is 1972846491, issued on 04/03/2013.
Does THOMAS MUELLEMAN, MD prescribe more brand-name or generic drugs?
THOMAS MUELLEMAN, MD's prescribing is 4% brand-name and 96% generic drugs by claim count, with $2K in brand drug costs.
Does THOMAS MUELLEMAN, MD prescribe opioids?
Yes, THOMAS MUELLEMAN, MD had 60 opioid claims in 2023 with an opioid prescribing rate of 10.2%.
How many Otology & Neurotology Physician providers are there in the US?
There are 333 Otology & Neurotology Physician providers across 46 states in the US. The average Otology & Neurotology Physician provider writes 401 Medicare Part D claims per year.
What drugs does THOMAS MUELLEMAN, MD prescribe most often?
Based on 2023 Medicare Part D data, THOMAS MUELLEMAN, MD's most frequently prescribed drugs include Ofloxacin, Cephalexin, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does THOMAS MUELLEMAN, MD accept Medicare?
THOMAS MUELLEMAN, MD appears in CMS Medicare data with 588 Part D claims and 221 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify THOMAS MUELLEMAN, MD's credentials?
THOMAS MUELLEMAN, MD's NPI is 1972846491 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology